A new method to treat hereditary cerebellar ataxia — umbilical cord mesenchymal stem cells trsplantation

A new method to treat hereditary cerebellar ataxia -- umbilical cord mesenchymal stem cells trsplantation

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONRC-12001869

Enrollment

Unknown

Registered

2012-01-09

Start date

2012-01-09

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hereditary cerebellar ataxia

Interventions

A:hereditary cerebellar ataxia

B:conventional therapy

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. 18-65 years of age; 2. Molecularly diagnosed SCA1.

Exclusion criteria

Exclusion criteria: 1. Cognitively impaired individuals; 2. Schizophrenics; 3. Patients with severe kidney and liver disease, epilepsy, theart disease, pulmonary disease, cardiac arrhythmia, diabetes insipidus, leukemia and some other central neural disease (such as Parkinson disease, accidence of brain vascular et al); 4. Age less than 18 years, age greater than 65 years.

Design outcomes

Primary

Measure	Time frame
Nerve functional evaluation;	—

Secondary

Measure	Time frame
somatosensory evoked potential;brain stem auditory evoked potential;	—

Countries

China

Contacts

Public ContactAn yihua

riveran@126.com+86 18600090033

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026